Skip to content

EURANDLAB: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

EURANDLAB

BE 0518.905.755
NACE 21.201, Manufacture of basic pharmaceutical products and pharmaceutical preparations
financial year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€33,599
2024 · €829,711-€796,112
Equity
€24,436
2024 · -€9,163+€33,599
Cash
€470
2024 · €3,630-€3,160
Balance sheet total
€27,845
2024 · €142,086-€114,241

Largest movements

2024 to 2025
Assets
  • Receivables within one year -€101,882

    down €101,882 (-84.2%), from €121,003 to €19,121

    of which Trade receivables: -€62,185

  • Stocks and contracts -€4,175

    no longer reported in 2025 (was €4,175)

  • Intangible fixed assets -€3,231

    down €3,231 (-28.1%), from €11,485 to €8,254

  • Cash -€3,160

    down €3,160 (-87.1%), from €3,630 to €470

    mainly Trade debts (-€149,968)

Equity and liabilities
  • Trade debts -€149,968

    down €149,968 (-99.2%), from €151,235 to €1,267

  • Profit (loss) carried forward +€33,599

    up €33,599 (+76.1%), from -€44,163 to -€10,564

  • Tax, wage and social debts +€1,758

    new in 2025: €1,758

Income statement
  • Financial income -€847,723

    down €847,723 (-96.2%), from €881,124 to €33,401

    of which Financial income: -€881,081

  • Gross operating margin +€47,354

    up €47,354, from -€39,956 to €7,398

  • Taxes +€1,758

    new in 2025: €1,758

  • Financial charges -€972

    down €972 (-68.7%), from €1,415 to €443

    of which Non-recurring financial charges: -€1,109

  • Depreciation -€841

    down €841 (-17.3%), from €4,865 to €4,024

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €829,711
Gross operating margin +€47,354
Depreciation +€841
Other operating charges -€17
Other operating items +€4,219
Financial income -€847,723
Financial charges +€972
Taxes -€1,758
Result 2025 €33,599

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€4,160
Investment +€1,000
Financing €0
Cash 2024 €3,630
Net result for the year +€33,599
Depreciation +€4,024
Stocks and contracts +€4,175
Receivables within one year +€101,882
Trade debts -€149,968
Tax, wage and social debts +€1,758
Other debts +€370
Investment in fixed assets (net) +€1,000
Cash 2025 €470
Every line side by side 40 lines
Line Code 2024 2025 Change %
Total assets 20/58 €142,086 €27,845 -€114,241 -80.4%
Fixed assets 21/28 €13,278 €8,254 -€5,024 -37.8%
Intangible fixed assets 21 €11,485 €8,254 -€3,231 -28.1%
Tangible fixed assets 22/27 €793 - -€793
Furniture and vehicles 24 €87 - -€87
Other tangible fixed assets 26 €706 - -€706
Financial fixed assets 28 €1,000 - -€1,000
Current assets 29/58 €128,808 €19,591 -€109,217 -84.8%
Stocks and contracts in progress 3 €4,175 - -€4,175
Stocks 30/36 €4,175 - -€4,175
Amounts receivable within one year 40/41 €121,003 €19,121 -€101,882 -84.2%
Trade receivables 40 €77,100 €14,915 -€62,185 -80.7%
Other amounts receivable 41 €43,903 €4,206 -€39,697 -90.4%
Cash at bank and in hand 54/58 €3,630 €470 -€3,160 -87.1%
Total equity and liabilities 10/49 €142,086 €27,845 -€114,241 -80.4%
Equity 10/15 -€9,163 €24,436 +€33,599
Contributions 10/11 €35,000 €35,000 = 0.0%
Profit (loss) carried forward 14 -€44,163 -€10,564 +€33,599 +76.1%
Amounts payable 17/49 €151,249 €3,409 -€147,840 -97.7%
Amounts payable within one year 42/48 €151,249 €3,409 -€147,840 -97.7%
Trade debts 44 €151,235 €1,267 -€149,968 -99.2%
Suppliers 440/4 €151,235 €1,267 -€149,968 -99.2%
Taxes, remuneration and social security 45 - €1,758 +€1,758
Taxes 450/3 - €1,758 +€1,758
Other amounts payable 47/48 €14 €384 +€370 +2642.9%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €4,865 €4,024 -€841 -17.3%
Other operating charges 640/8 €483 €500 +€17 +3.5%
Non-recurring operating charges 66A €4,694 €475 -€4,219 -89.9%
Gross operating margin 9900 -€39,956 €7,398 +€47,354
Operating profit (loss) 9901 -€49,998 €2,399 +€52,397
Financial income 75/76B €881,124 €33,401 -€847,723 -96.2%
Recurring financial income 75 €881,124 €43 -€881,081 -100.0%
Non-recurring financial income 76B €881,124 €33,358 -€847,766 -96.2%
Financial charges 65/66B €1,415 €443 -€972 -68.7%
Recurring financial charges 65 €306 €443 +€137 +44.8%
Non-recurring financial charges 66B €1,109 - -€1,109
Profit (loss) for the period before taxes 9903 €829,711 €35,357 -€794,354 -95.7%
Income taxes 67/77 - €1,758 +€1,758
Profit (loss) for the period 9904 €829,711 €33,599 -€796,112 -96.0%
Profit (loss) for the period to be appropriated 9905 €829,711 €33,599 -€796,112 -96.0%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 12 October 2026 via checked.be.